Cargando…
Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure
The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066162/ https://www.ncbi.nlm.nih.gov/pubmed/33810401 http://dx.doi.org/10.3390/v13040562 |
_version_ | 1783682510155153408 |
---|---|
author | Loveday, Emma K. Hain, Kyle S. Kochetkova, Irina Hedges, Jodi F. Robison, Amanda Snyder, Deann T. Brumfield, Susan K. Young, Mark J. Jutila, Mark A. Chang, Connie B. Taylor, Matthew P. |
author_facet | Loveday, Emma K. Hain, Kyle S. Kochetkova, Irina Hedges, Jodi F. Robison, Amanda Snyder, Deann T. Brumfield, Susan K. Young, Mark J. Jutila, Mark A. Chang, Connie B. Taylor, Matthew P. |
author_sort | Loveday, Emma K. |
collection | PubMed |
description | The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study, we validated and compared two protocols for inactivating SARS-CoV-2: heat treatment and ultraviolet irradiation. The two methods were optimized to render the virus completely incapable of infection while limiting the destructive effects of inactivation. We observed that 15 min of incubation at 65 °C completely inactivates high titer viral stocks. Complete inactivation was also achieved with minimal amounts of UV power (70,000 µJ/cm(2)), which is 100-fold less power than comparable studies. Once validated, the two methods were then compared for viral RNA quantification, virion purification, and antibody detection assays. We observed that UV irradiation resulted in a 2-log reduction of detectable genomes compared to heat inactivation. Protein yield following virion enrichment was equivalent for all inactivation conditions, but the quality of resulting viral proteins and virions were differentially impacted depending on inactivation method and time. Here, we outline the strengths and weaknesses of each method so that investigators might choose the one which best meets their research goals. |
format | Online Article Text |
id | pubmed-8066162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80661622021-04-25 Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure Loveday, Emma K. Hain, Kyle S. Kochetkova, Irina Hedges, Jodi F. Robison, Amanda Snyder, Deann T. Brumfield, Susan K. Young, Mark J. Jutila, Mark A. Chang, Connie B. Taylor, Matthew P. Viruses Article The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study, we validated and compared two protocols for inactivating SARS-CoV-2: heat treatment and ultraviolet irradiation. The two methods were optimized to render the virus completely incapable of infection while limiting the destructive effects of inactivation. We observed that 15 min of incubation at 65 °C completely inactivates high titer viral stocks. Complete inactivation was also achieved with minimal amounts of UV power (70,000 µJ/cm(2)), which is 100-fold less power than comparable studies. Once validated, the two methods were then compared for viral RNA quantification, virion purification, and antibody detection assays. We observed that UV irradiation resulted in a 2-log reduction of detectable genomes compared to heat inactivation. Protein yield following virion enrichment was equivalent for all inactivation conditions, but the quality of resulting viral proteins and virions were differentially impacted depending on inactivation method and time. Here, we outline the strengths and weaknesses of each method so that investigators might choose the one which best meets their research goals. MDPI 2021-03-26 /pmc/articles/PMC8066162/ /pubmed/33810401 http://dx.doi.org/10.3390/v13040562 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Loveday, Emma K. Hain, Kyle S. Kochetkova, Irina Hedges, Jodi F. Robison, Amanda Snyder, Deann T. Brumfield, Susan K. Young, Mark J. Jutila, Mark A. Chang, Connie B. Taylor, Matthew P. Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure |
title | Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure |
title_full | Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure |
title_fullStr | Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure |
title_full_unstemmed | Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure |
title_short | Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure |
title_sort | effect of inactivation methods on sars-cov-2 virion protein and structure |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066162/ https://www.ncbi.nlm.nih.gov/pubmed/33810401 http://dx.doi.org/10.3390/v13040562 |
work_keys_str_mv | AT lovedayemmak effectofinactivationmethodsonsarscov2virionproteinandstructure AT hainkyles effectofinactivationmethodsonsarscov2virionproteinandstructure AT kochetkovairina effectofinactivationmethodsonsarscov2virionproteinandstructure AT hedgesjodif effectofinactivationmethodsonsarscov2virionproteinandstructure AT robisonamanda effectofinactivationmethodsonsarscov2virionproteinandstructure AT snyderdeannt effectofinactivationmethodsonsarscov2virionproteinandstructure AT brumfieldsusank effectofinactivationmethodsonsarscov2virionproteinandstructure AT youngmarkj effectofinactivationmethodsonsarscov2virionproteinandstructure AT jutilamarka effectofinactivationmethodsonsarscov2virionproteinandstructure AT changconnieb effectofinactivationmethodsonsarscov2virionproteinandstructure AT taylormatthewp effectofinactivationmethodsonsarscov2virionproteinandstructure |